Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
米非司酮墮胎藥的供應陷入困境：司法部可能會要求最高法院進行干預
- U.S. Attorney General Merrick Garland said that the Justice Department would file an appeal with the U.S. Supreme Court seeking to block the entirety of Kacsmaryk's order suspending the FDA approval of the abortion pill mifepristone.
- Garland said the administration "will be seeking emergency relief from the Supreme Court to defend the FDA's scientific judgment and protect Americans' access to safe and effective reproductive care."
- The New Orleans-based 5th U.S. Circuit Court of Appeals put on hold part of last Friday's order by U.S. District Judge Matthew Kacsmaryk in Amarillo, Texas, while he hears a lawsuit by anti-abortion groups seeking to ban it.
- The Planned Parenthood Federation of America condemned the 5th Circuit's decision as a rejection of science and law.
- "The federal judiciary has — for the second time this week — rejected science and the law, and this time, the court decided they had the authority to re-write mifepristone's label," CNBC reported citing Alexis McGill Johnson, president of Planned Parenthood.
- "If allowed to stand, the consequences of this decision will be catastrophic not just for medication abortion access but the entire drug approval system," he added.
- A U.S. federal appeals court has temporarily blocked a decision by a Texas judge.
- The abortion pill mifepristone will remain available in the U.S. for now but with some restrictions, including requiring in-person doctor visits to obtain the drug and limiting its use to the first seven weeks of pregnancy from the current ten, a federal appeals court ruled.
- 美國司法部長梅里克·加蘭說，司法部將向美國最高法院提起上訴，要求阻止Kacsmaryk暫停美國食品藥品管理局批准墮胎藥米非司酮的全部命令。
- 加蘭說，政府 “將向最高法院尋求緊急救濟，以捍衛美國食品藥品管理局的科學判斷，保護美國人獲得安全有效的生殖保健的機會。”
- 總部位於新奧爾良的美國第五巡迴上訴法院暫停了美國地方法院法官馬修·卡斯馬里克上週五在德克薩斯州阿馬裏洛下達的部分命令，當時他正在審理反墮胎組織提起的旨在禁止該命令的訴訟。
- 美國計劃生育聯合會譴責第五巡迴法院的決定，認爲這是對科學和法律的拒絕。
- CNBC援引計劃生育組織主席亞歷克西斯·麥吉爾·約翰遜的話報道：“聯邦司法機構本週第二次拒絕了科學和法律，這次，法院裁定他們有權改寫米非司通的標籤。”
- 他補充說：“如果允許的話，這一決定的後果將是災難性的，不僅會影響藥物流產的獲取，而且會影響整個藥物批准系統。”
- 美國聯邦上訴法院暫時阻止了得克薩斯州法官的裁決。
- 聯邦上訴法院裁定，墮胎藥米非司酮目前仍將在美國上市，但有一些限制，包括要求當面看醫生才能獲得該藥物，並將其使用從目前的十週限制在妊娠的前七週。